Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Borison

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
The American Journal of Psychiatry|January 1, 1979
Amantadine-induced psychosis in a geriatric patient with renal diseaseR L Borison
Journal of Clinical Psychopharmacology|February 1, 1995
Clinical efficacy of serotonin-dopamine antagonists relative to classic neurolepticsR L Borison
Harvard Review of Psychiatry|January 1, 1997
Recent advances in the pharmacotherapy of schizophreniaR L Borison
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1996
The role of cognition in the risk--benefit and safety analysis of antipsychotic medicationR L Borison
Clinical Therapeutics|July 1, 1996
Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone DosingR L Borison
The Journal of Clinical Psychiatry|April 1, 1985
Pharmacology of antipsychotic drugsR L Borison
Clinical Neuropharmacology|January 1, 1983
Amantadine in the management of extrapyramidal side effectsR L Borison
The Journal of Nervous and Mental Disease|October 1, 1995
Paroxetine treatment of anger associated with depressionJ Albritton, R L Borison
Psychiatric Medicine|January 1, 1990
New advances in psychotherapeutic agents: clozapineR L Borison, B I Diamond
Neurology|November 1, 1978
Enkephalins and nigrostriatal functionB I Diamond, R L Borison
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
The American Journal of Psychiatry|January 1, 1979
Amantadine-induced psychosis in a geriatric patient with renal diseaseR L Borison
Journal of Clinical Psychopharmacology|February 1, 1995
Clinical efficacy of serotonin-dopamine antagonists relative to classic neurolepticsR L Borison
Harvard Review of Psychiatry|January 1, 1997
Recent advances in the pharmacotherapy of schizophreniaR L Borison
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1996
The role of cognition in the risk--benefit and safety analysis of antipsychotic medicationR L Borison
Clinical Therapeutics|July 1, 1996
Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone DosingR L Borison
The Journal of Clinical Psychiatry|April 1, 1985
Pharmacology of antipsychotic drugsR L Borison
Clinical Neuropharmacology|January 1, 1983
Amantadine in the management of extrapyramidal side effectsR L Borison
The Journal of Nervous and Mental Disease|October 1, 1995
Paroxetine treatment of anger associated with depressionJ Albritton, R L Borison
Psychiatric Medicine|January 1, 1990
New advances in psychotherapeutic agents: clozapineR L Borison, B I Diamond
Neurology|November 1, 1978
Enkephalins and nigrostriatal functionB I Diamond, R L Borison
Pageof 7